Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p21 Disrupts the interaction between cdk2 and the E2F-p130 complex

P Shiyanov1, S Bagchi, G Adami

  • 1Department of Biochemistry, University of Illinois at Chicago, Illinois 60612, USA.

Molecular and Cellular Biology
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The global extent of the grassland biome and implications for the terrestrial carbon sink.

Nature ecology & evolution·2026
Same author

Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries.

IJTLD open·2025
Same author

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries.

IJTLD open·2025
Same author

Greater than Five-Order-of-Magnitude Postcompression Temporal Contrast Improvement with an Ionization Plasma Grating.

Physical review letters·2024
Same author

Diffuse idiopathic skeletal hyperostosis is associated with greater complexity of coronary artery disease burden on coronary angiography.

Reumatismo·2024
Same author

Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report.

Reumatismo·2024

The p21 protein disrupts the E2F-p130 complex, releasing cdk2 and inhibiting cell cycle progression. This finding suggests p21 mediates p53

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • Transcription factor E2F binds retinoblastoma-related protein p130 in growth-arrested cells, inhibiting cell cycle progression.
  • Cyclin-dependent kinase 2 (cdk2) binds to the E2F-p130 complex during G1 phase progression.

Purpose of the Study:

  • To investigate the role of p21 in the disruption of the E2F-p130-cdk2 complex.
  • To elucidate the mechanism by which p53-mediated growth suppression occurs.

Main Methods:

  • Fractionation of mouse L-cell extracts to isolate the E2F-p130-cdk2 complex.
  • Incubation of the complex with recombinant p21 in cell lines expressing a temperature-sensitive p53 mutant.
  • Analysis of reporter gene expression containing E2F binding sites.

Related Experiment Videos

Main Results:

  • Recombinant p21 disrupted the interaction between cdk2 and the E2F-p130 complex.
  • Increased p21 levels correlated with reduced cdk2 association with the E2F-p130 complex.
  • p21 coexpression reduced the activity of a reporter gene driven by E2F-responsive elements.

Conclusions:

  • The p21 protein mediates the disruption of the E2F-p130-cdk2 complex.
  • This disruption is a key mechanism in the growth-suppressive function of p53.